It has been recently hypothesized that infection by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) may lead to fibrotic sequelae in patients recovering from coronavirus disease 2019 (COVID-19). In this observational study, hospitalized patients with COVID-19 had a HRCT of the chest performed to detect the extension of fibrotic abnormalities via Hounsfield Units (HU). At follow-up, the lung density significantly improved in both lungs and in each lobe of all patients, being in the normal range (− 950 to − 700 HU). This study provides preliminary evidence that hospitalized patients with mild-to-moderate forms of COVID-19 are not at risk of developing pulmonary fibrosis.
All Keywords
【저자키워드】 COVID-19, pulmonary fibrosis, HRCT, 【초록키워드】 coronavirus disease, SARS-CoV-2, coronavirus, Infection, lung, risk, Chest, Patient, Follow-up, patients, Evidence, Mild-to-moderate, acute respiratory syndrome, unit, extension, abnormality, performed, detect, significantly, form, provide, hospitalized patient, with COVID-19, 【제목키워드】 Patient,
【저자키워드】 COVID-19, pulmonary fibrosis, HRCT, 【초록키워드】 coronavirus disease, SARS-CoV-2, coronavirus, Infection, lung, risk, Chest, Patient, Follow-up, patients, Evidence, Mild-to-moderate, acute respiratory syndrome, unit, extension, abnormality, performed, detect, significantly, form, provide, hospitalized patient, with COVID-19, 【제목키워드】 Patient,